DeveloGen
HOME COMPANY PRODUCTS SERVICES NEWS AND PRESS CAREER
 You are here    Home / Contract Services / Overview /
 
News and Press
Overview
 
Latest News
Press Releases

Jul 14th, 2010
Evotec AG to Acquire Majority Holding in DeveloGen AG
download PDF (english, 22 KB)
download PDF (deutsch, 24 KB)

Feb 23rd, 2010
DeveloGen AG receives US$ 500.000 Funding from the Juvenile Diabetes Research Foundation for Beta Cell Research
download PDF (english, 158 KB)
download PDF (deutsch, 160 KB)

Nov 9th, 2009
Scientists at TU Braunschweig and DeveloGen AG receive Phoenix Science Award 2009 for a publication in the field of beta cell regeneration
download PDF (english, 21 KB)
download PDF (deutsch, 21 KB)

May 13th, 2009
Boehringer Ingelheim and DeveloGen AG announce agreement in the field of diabetes, obesity and the metabolic syndrome
download PDF (english,48 KB)
download PDF (deutsch, 49 KB)

February 26th, 2009
DeveloGen Reports Positive Phase 1 Clinical Trial Results for DG3173
download PDF (english,145 KB)
download PDF (deutsch, 148 KB)

October 8th, 2008
DeveloGen Announces Completion of a Phase 1 Clinical Trial of DG3173, a Novel Somatostatin Analogue for the Treatment of Acromegaly
download PDF (english, 49 KB)
download PDF (deutsch, 51 KB)


Articles

April 10th, 2008
Latest Publication in Journal of Medical Chemistry: "9-cyano-1-azapaullone (cazpaullone), a glycogen synthase kinase-3 (GSK-3) inhibitor activating pancreatic beta cell protection and replication"
(read more)

January 22th, 2007
Latest Publication in Journal of Biological Chemistry: "Inhibition of Glycogen Synthase Kinase (GSK) 3 Promotes Replication and Survival of Pancreatic Beta Cells"
(read more)

February 15th, 2005
Latest Publication in Drug Discovery Today: "Phenotype-first screening for the identification of novel drug targets"
(read more)

February 1st, 2005
Latest Publication in Physiol Genomics: "Expression of uncoupling protein 1 (UCP1) in skeletal muscle decreases muscle energy efficiency and affects thermoregulation and substrate oxidation"
(read more)

December 20th, 2004
Latest Publication in The Journal of Cell Biology: "The diabetes-linked transcription factor PAX4 promotes β-cell proliferation and survival in rat and human islets"
(read more)

September 9th, 2004
Invited article: "Target discovery in metabolic disease" in Drug Discovery Today by C. Dohrmann, CSO, DeveloGen AG
(read more)

 
Supplements
DeveloGen AG
Marie-Curie-Str. 7
37079 Goettingen
Germany

tel: +49 (0)551-50 558 0
fax: +49 (0)551-50 558 588

email: info@develogen.com
Kooperationspreis 2002 des Landes Niedersachsen
Kooperationspreis 2002
des Landes Niedersachsens

  SITEMAP      IMPRINT       CONTACT